NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹77 Cr | ₹34 Cr | ₹32 Cr | ₹30 Cr | ₹16 Cr |
What is the latest Total Debt ratio of NGL FINECHEM ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹77 Cr |
| Mar2024 | ₹34 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹30 Cr |
| Mar2021 | ₹16 Cr |
How is Total Debt of NGL FINECHEM Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹77 Cr | 126.73 | |
| Mar2024 | ₹34 Cr | 4.63 | |
| Mar2023 | ₹32 Cr | 8.32 | |
| Mar2022 | ₹30 Cr | 82.41 | |
| Mar2021 | ₹16 Cr | - | |
Compare Total Debt of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,376.1 Cr | 21.7% | 49.8% | 34.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,991.0 Cr | 0.1% | -3.2% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,371.0 Cr | -1.5% | -7.3% | 2.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,229.0 Cr | -1.3% | -0.7% | 24.4% | Stock Analytics | |
| CIPLA | ₹108,441.0 Cr | 1.5% | -8.1% | -6.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,407.0 Cr | 3.2% | 5.6% | 3.1% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 21.7% |
49.8% |
34.6% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses